Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody (GB221) for Injection [Phase 3]
Phase 3 clinical trial update for Recombinant Anti-HER2 humanized monoclonal antibody GB221 in HER-2-positive advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-11-14Clinical Trial Update: NeoPHOEBE: Neoadjuvant Trastuzumab + BKM120 in Combination With Weekly Paclitaxel in HER2-positive Primary Breast Cancer [Phase 2]
Phase 2 trial of neoadjuvant trastuzumab plus BKM120 with weekly paclitaxel in HER2-positive primary breast cancer completed; results posted…
-
CLINICAL_TRIALS trial_result · 2019-11-13Clinical Trial Update: Neoadjuvant Carboplatin and Docetaxel in Triple Negative Breast Cancer [Phase 2]
This update reports a Phase 2 neoadjuvant study of carboplatin plus docetaxel in triple-negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-11-13Clinical Trial Update: A Study of Cobimetinib Plus Paclitaxel, Cobimetinib Plus Atezolizumab Plus Paclitaxel, or Cobimetinib Plus Atezolizumab Plus Nab-Paclitaxel as Initial Treatment for Participants With Triple-Negative Breast Cancer That Has Spread [Phase 2]
Phase 2 clinical trial update investigating cobimetinib combinations with paclitaxel, atezolizumab-based regimens for metastatic triple-nega…
-
CLINICAL_TRIALS research · 2019-11-13Clinical Trial Update: Pilot Study of Cabazitaxel and Paclitaxel in HER2 Negative Breast Cancer [Phase 2]
Pilot Phase 2 trial updating on cabazitaxel and paclitaxel in HER2-negative metastatic breast cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-11-13Clinical Trial Update: Assessing Response to Neoadjuvant Chemotherapy With HD PET/CT, Serum Glycomic Markers and Tissue Muc-1 Isoforms [NA]
A completed clinical trial evaluating neoadjuvant chemotherapy response using HD PET/CT, serum glycomic markers, and tissue Muc-1 isoforms i…
-
CLINICAL_TRIALS trial_result · 2019-11-12Clinical Trial Update: Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS Metastasis [Phase 1, Phase 2]
Phase 1b/2 trial evaluating lapatinib, everolimus, and capecitabine for HER2-positive breast cancer with CNS metastases has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-06Clinical Trial Update: Various G-CSF Regimens to Prevent Infection During Chemotherapy [Phase 3]
Phase 3 trial update evaluating various G-CSF regimens to prevent infection in chemotherapy for breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-11-05Clinical Trial Update: Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast Cancer [Phase 1, Phase 2]
Clinical trial update for pyrotinib maleate tablets in combination with albumin paclitaxel and trastuzumab in HER2-positive breast cancer (P…
-
FDA approval · 2019-11-01FDA Approved: IBRANCE — Original Application (U.S. Pharmaceuticals)
FDA approved IBRANCE (palbociclib) in its original application for HR-positive, HER2-negative advanced or metastatic breast cancer in postme…
-
CLINICAL_TRIALS trial_result · 2019-11-01Clinical Trial Update: Neoadjuvant Paclitaxel Plus Epirubicin Versus Vinorelbine Plus Epirubicin in Breast Cancer With TEKT4 Variations [Phase 2]
Phase 2 trial comparing neoadjuvant paclitaxel plus epirubicin versus vinorelbine plus epirubicin in breast cancer with TEKT4 variations com…
-
CLINICAL_TRIALS trial_result · 2019-11-01Clinical Trial Update: Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast Cancer [Phase 2]
Phase 2 trial comparing enzastaurin plus fulvestrant versus placebo plus fulvestrant in breast cancer has completed with results posted.
-
CLINICAL_TRIALS research · 2019-11-01Clinical Trial Update: Women in Steady Exercise Research [Formerly Women, Oxidative Stress, Exercise and Estrogens (WOSEE)] [Phase 2, Phase 3]
A Phase 2/3 clinical trial update exploring exercise effects in women, originally WOSEE, focusing on breast cancer and obesity outcomes. Stu…
-
CLINICAL_TRIALS trial_result · 2019-10-31Clinical Trial Update: Subharmonic Imaging and Pressure Estimation for Monitoring Neoadjuvant Chemotherapy [NA]
This ClinicalTrials.gov update notes that the trial investigating subharmonic imaging and pressure estimation to monitor neoadjuvant chemoth…
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer [Phase 2]
Phase 2 trial evaluating omega-3 fatty acid in treating various stages of breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: Vinorelbine/Carboplatin Versus Gemcitabine/Carboplatin in Metastatic Breast Cancer [Phase 2]
Phase 2 trial comparing Vinorelbine/Carboplatin versus Gemcitabine/Carboplatin in metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-10-29Clinical Trial Update: Efficacy and Safety Evaluating Study of CT-P6 in Her2 Positive Early Breast Cancer [Phase 3]
Phase 3 trial updating efficacy and safety of CT-P6 in HER2-positive breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-29Clinical Trial Update: The Impact of Intravenous Anaesthesia on Angiogenesis in Patients With Breast Cancer (TIVA/TCI-BC) [Phase 2]
Phase 2 clinical trial update evaluating the impact of intravenous anesthesia on angiogenesis in patients with breast cancer has completed.
-
CLINICAL_TRIALS research · 2019-10-29Clinical Trial Update: Safety Study of Pertuzumab (in Combination With Trastuzumab and Docetaxel) in Indian Participants With Breast Cancer [Phase 4]
Phase 4 safety study of pertuzumab in combination with trastuzumab and docetaxel in Indian participants with breast cancer has completed; re…
-
CLINICAL_TRIALS trial_result · 2019-10-28Clinical Trial Update: MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment [Phase 1]
Phase 1 trial of MM-398 (Nal-IRI) investigates tumor drug levels and feasibility of using ferumoxytol-enhanced MRI to measure tumor-associat…
-
FDA approval · 2019-10-25FDA Approved: KANJINTI — Supplemental Application (Amgen, Inc)
FDA approved a supplemental application for KANJINTI (trastuzumab-anns) submitted by Amgen, Inc. The action represents a regulatory approval…
-
CLINICAL_TRIALS trial_result · 2019-10-25Clinical Trial Update: Maintenance Treatment With Capecitabine Versus Observation in Breast Cancer Patients [Phase 3]
Phase 3 trial comparing maintenance capecitabine to observation in breast cancer patients completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-25Clinical Trial Update: EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer [Phase 3]
Phase 3 trial comparing EC followed by docetaxel versus ET followed by capecitabine as adjuvant chemotherapy in node-positive operable breas…
-
CLINICAL_TRIALS trial_result · 2019-10-25Clinical Trial Update: Acute Exercise Cardioprotection From Doxorubicin [Phase 1]
Phase 1 clinical trial investigating acute exercise cardioprotection against doxorubicin in breast cancer; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-25Clinical Trial Update: Pilot Study for a Prospective Surveillance Program for Rehabilitation Following Surgery for Breast Cancer [NA]
Pilot study update for a prospective surveillance program following breast cancer surgery; study completed with results posted.